Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production
about
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifsThe human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidYY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infectionRepression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSFDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyTargeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter.A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region.A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replicationUse of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progressionExon level transcriptomic profiling of HIV-1-infected CD4(+) T cells reveals virus-induced genes and host environment favorable for viral replication.Functional interactions between YY1 and adenovirus E1A.High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster.An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.Viral-host interactions that control HIV-1 transcriptional elongationZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.An enhancer of recombination in polyomavirus DNAYY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.Regulation of Yin Yang 1 by Tyrosine Phosphorylation.Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element.The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activityCNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.Regulation of HIV-1 latency by T-cell activation.NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-IValproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.HIV-1 Latency and Eradication: Past, Present and FutureFunction of YY1 in Long-Distance DNA Interactions.Control of HIV latency by epigenetic and non-epigenetic mechanisms.Reactivation of latent HIV by histone deacetylase inhibitors.Lost in transcription: molecular mechanisms that control HIV latencyDNA binding sites for the transcriptional activator/repressor YY1.Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.
P2860
Q24317451-C5A70884-2D5D-4ABB-BCCD-828FEC7C2389Q24525309-B93144F0-88A6-4837-869A-0882A6795EAFQ24537275-65C713C3-5582-4F3A-817A-D307E0FFFDDAQ24596282-8DFC0402-E299-4949-8190-11EC656057FDQ24646624-D0DD1F1A-1494-4CB3-93B3-CC4E77BC2517Q24653519-96AB75AA-4206-49E8-8B7E-3C902480280EQ28111910-99A996D4-12B5-4B93-98B6-2BEEBFEE8F3AQ28213125-4C1C6371-FE9E-4491-B12E-21B36F2A74E0Q30452606-71B7F89F-11D7-45BE-9F43-E95FF038DBBBQ33556837-74C9F8CF-777D-4C5B-AA76-22F104F9E465Q33613718-3DAA28C4-8A6E-44A5-B821-D18D2E56DB2EQ33641032-AD2CDCA4-86F6-4C11-ACD0-DF390351353AQ33785650-3B090E89-74A0-4892-9383-68CD1769CF4BQ34045563-36986A78-F511-4ACD-B960-AD536573E739Q34372339-FC02D302-D2A2-4FA2-83A4-2F1ABF118C16Q34742589-34255A09-34EE-4054-A8AA-3D70F58ED10DQ34778482-BC3D38B4-56B9-4A9D-9EA7-5E367A1AB06FQ35015033-080AFF70-4877-4691-A13E-5F2529309DCAQ35026881-FEA35879-1F9F-4BD5-BE21-44E4DAECFD7DQ35034218-93FA30B0-B9F1-4921-A6F0-5008B9FE06D9Q35828407-3FE941A4-E4BC-4A7A-8525-51B42B0F1B33Q35841116-B899EA4E-8785-43D7-B436-B2C56CF52B41Q35864965-E9B67499-E692-40FD-8DE2-DFD2D41BA9F1Q35869296-49947EFD-08E9-4327-92FA-A7EC9794CA8EQ35881644-AFAE986D-AD35-480A-A9AD-B68E2A097338Q36065209-5ED50FF5-A389-44B6-A88E-EB48F67C7419Q36157946-91518789-E05F-4D54-B7BF-114F8E125B30Q36561971-6FB9E965-02FD-4B57-BD26-65B15643489CQ36636990-88C631FD-2CBE-4873-AEDA-F0D27A8159BFQ36719187-106D44AB-45AE-4645-B50F-CBF02C45F639Q36887625-CA4DAF96-B670-4622-9FCB-35853439FF10Q37237849-518AAA43-6531-4701-BB87-18444B502EA7Q37393518-739E1572-A905-4229-B276-A65DC8D77018Q37505823-2765C50F-A2D6-46E6-A092-0FF703781B46Q37570810-629B02DE-1EEA-433D-B034-CAA435E1A3B5Q37972643-D17CD1C2-B659-444C-BC1B-BE93B83D0D23Q38091753-4E789B98-5C65-4881-AE1B-8BCA7F7E2D8AQ38091888-08CF12FA-8806-4EAA-AA0E-0ED1FD66F7D7Q38289296-0B1D0166-B76B-4655-8FE7-12BC3219D46FQ38296043-FB116BD4-3CE3-42AB-9DD2-3C84ED518E52
P2860
Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human transcription factor YY1 ...... cription and virion production
@ast
Human transcription factor YY1 ...... cription and virion production
@en
Human transcription factor YY1 ...... cription and virion production
@nl
type
label
Human transcription factor YY1 ...... cription and virion production
@ast
Human transcription factor YY1 ...... cription and virion production
@en
Human transcription factor YY1 ...... cription and virion production
@nl
prefLabel
Human transcription factor YY1 ...... cription and virion production
@ast
Human transcription factor YY1 ...... cription and virion production
@en
Human transcription factor YY1 ...... cription and virion production
@nl
P2093
P2860
P1433
P1476
Human transcription factor YY1 ...... cription and virion production
@en
P2093
D M Margolis
M Somasundaran
P2860
P304
P407
P577
1994-02-01T00:00:00Z